BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9864170)

  • 1. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    Dai J; Weinberg RS; Waxman S; Jing Y
    Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium arsenite and arsenic trioxide differently affect the oxidative stress of lymphoblastoid cells: An intricate crosstalk between mitochondria, autophagy and cell death.
    Rainey NE; Armand AS; Petit PX
    PLoS One; 2024; 19(5):e0302701. PubMed ID: 38728286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia.
    Yedjou C; Thuisseu L; Tchounwou C; Gomes M; Howard C; Tchounwou P
    Arch Drug Inf; 2009 Dec; 2(4):59-65. PubMed ID: 20098508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ascorbic acid and hydrogen peroxide on mouse neuroblastoma cells.
    Hardaway CM; Badisa RB; Soliman KF
    Mol Med Rep; 2012 Jun; 5(6):1449-52. PubMed ID: 22469841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress on arsenic, arsenic-containing medicinal materials, and arsenic-containing preparations: clinical application, pharmacological effects, and toxicity.
    Yang Y; Li Y; Li R; Wang Z
    Front Pharmacol; 2024; 15():1338725. PubMed ID: 38495096
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications.
    Jiang Y; Shen X; Zhi F; Wen Z; Gao Y; Xu J; Yang B; Bai Y
    Cell Death Discov; 2023 Jul; 9(1):266. PubMed ID: 37500645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond.
    Kumana CR; Kwong YL; Gill H
    Front Oncol; 2022; 12():1026478. PubMed ID: 36518307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases.
    Chin L; Kumana CR; Kwong YL; Gill H
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-β/Smad2/3 and Jak2/Stat3 pathways through oxidative stress.
    Zhang X; Zheng C; Gao Z; Wang L; Chen C; Zheng Y; Meng Y
    J Cell Mol Med; 2021 Nov; 25(22):10711-10723. PubMed ID: 34687136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide.
    Zheng Y; Mao YF; Zhao HJ; Chen L; Wang LN; Zhang YX; Hu J; Li JM; Li XY; Zhu HM
    Exp Hematol Oncol; 2021 Feb; 10(1):10. PubMed ID: 33549147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolidine Dithiocarbamate Facilitates Arsenic Trioxide Against Pancreatic Cancer via Perturbing Ubiquitin-Proteasome Pathway.
    Yu S; Wu N; Zhu J; Liu Y; Han J
    Cancer Manag Res; 2020; 12():13149-13159. PubMed ID: 33376406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Cancer Activity of As
    Noh JJ; Kim MS; Cho YJ; Jeong SY; Lee YY; Ryu JY; Choi JJ; Bae I; Wu Z; Kim BG; Hwang JR; Lee JW
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33086573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Cisplatin: Combination Therapy with Arsenic Trioxide.
    Miodragović Ð; Swindell EP; Waxali ZS; Bogachkov A; O'Halloran TV
    Inorganica Chim Acta; 2019 Oct; 496():. PubMed ID: 32863421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside.
    Kumana CR; Mak R; Kwong YL; Gill H
    Front Oncol; 2020; 10():1294. PubMed ID: 32850403
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhao G; Dong R; Teng J; Yang L; Liu T; Wu X; He Y; Wang Z; Pu H; Wang Y
    ACS Omega; 2020 May; 5(20):11710-11720. PubMed ID: 32478262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Reactive Oxygen Species in the Cytotoxicity of Arsenic Trioxide and Pamidronate for Human Prostate Cancer Cells.
    Doroshow JH; Gaur S
    React Oxyg Species (Apex); 2020 Mar; 9(26):81-94. PubMed ID: 32337366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Ascorbic Acid and α-Tocopherol Synergistically Triggers Apoptosis Inducing Antileukemic Effects of Arsenic Trioxide
    Vineetha RC; Hariharan S; Jaleel A; Chandran M; Nair RH
    Front Oncol; 2020; 10():65. PubMed ID: 32154163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies.
    Hussain A; AlAjmi MF; Rehman MT; Amir S; Husain FM; Alsalme A; Siddiqui MA; AlKhedhairy AA; Khan RA
    Sci Rep; 2019 Mar; 9(1):5237. PubMed ID: 30918270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces the apoptosis and decreases NF-κB expression in lymphoma cell lines.
    Zhong L; Xu F; Chen F
    Oncol Lett; 2018 Nov; 16(5):6267-6274. PubMed ID: 30333888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lomefloxacin Induces Oxidative Stress and Apoptosis in COLO829 Melanoma Cells.
    Beberok A; Wrześniok D; Szlachta M; Rok J; Rzepka Z; Respondek M; Buszman E
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.